Markets:

Overview

News

Currencies

International

Treasuries

ResMed Inc. Common Stock (NY:RMD)

256.55 +5.04 (+2.00%)

Official Closing Price Updated: 7:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stay informed with the top movers within the S&P500 index on Monday. ↗

August 04, 2025

Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

The Analyst Verdict: ResMed In The Eyes Of 8 Experts ↗

August 01, 2025

Via Benzinga

ResMed Analysts Increase Their Forecasts After Strong Q2 Earnings ↗

August 01, 2025

Via Benzinga

ResMed (RMD) Stock Is Up, What You Need To Know

August 01, 2025

Shares of medical device company ResMed (NYSE:RMD) jumped 3.1% in the afternoon session after the company reported strong fourth-quarter financial results that surpassed analyst estimates.

Via StockStory

Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday? ↗

July 31, 2025

A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp.

Via Benzinga

Topics Economy

Earnings Scheduled For July 31, 2025 ↗

July 31, 2025

Via Benzinga

Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday ↗

August 01, 2025

Via Benzinga

ResMed (NYSE:RMD) Surprises With Q2 Sales

July 31, 2025

Medical device company ResMed (NYSE:RMD) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 10.2% year on year to $1.35 billion. Its non-GAAP profit of $2.55 per share was 3% above...

Via StockStory

Resmed Inc. (NYSE:RMD) Beats Q4 2025 Revenue and EPS Estimates Despite Muted Market Reaction ↗

July 31, 2025

Resmed Inc. (NYSE:RMD) beats Q4 2025 revenue and EPS estimates, reporting $1.35B and $2.55, respectively. Stock dips slightly amid muted market reaction despite strong growth and dividend hike.

Via Chartmill

Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2025

July 31, 2025

From Resmed, Inc.

Via GlobeNewswire

ResMed (RMD) To Report Earnings Tomorrow: Here Is What To Expect

July 29, 2025

Medical device company ResMed (NYSE:RMD) will be reporting earnings this Thursday afternoon. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

Analyst Expectations For ResMed's Future ↗

July 16, 2025

Via Benzinga

2 Reasons to Watch RMD and 1 to Stay Cautious

July 15, 2025

ResMed trades at $254.11 per share and has stayed right on track with the overall market, gaining 8.9% over the last six months. At the same time, the S&P 500 has returned 5.4%.

Via StockStory

Topics Government Stocks

Motley Fool Co-Founder David Gardner Reviews Stock Picks ↗

July 11, 2025

Via The Motley Fool

2 S&P 500 Stocks with Promising Prospects and 1 to Steer Clear Of

July 09, 2025

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Via StockStory

Topics Economy Stocks

Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025

July 01, 2025

From Resmed, Inc.

Via GlobeNewswire

RESMED INC (NYSE:RMD) – A Strong Candidate for Quality Investors ↗

July 01, 2025

RESMED INC (NYSE:RMD) is a high-quality stock with strong revenue growth, exceptional ROIC, and solid cash flow, making it a standout pick for long-term investors.

Via Chartmill

2 Cash-Producing Stocks to Consider Right Now and 1 to Ignore

June 19, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

Looking Back on a Motley Fool Career ↗

June 17, 2025

Via The Motley Fool

ResMed: A Mixed Bag for Investors Amid Rising Competition ↗

June 10, 2025

Via The Motley Fool

RESMED INC (NYSE:RMD) – A Strong Contender for Quality Investors ↗

June 09, 2025

RESMED INC (NYSE:RMD) is a high-quality stock with strong profitability, low debt, and consistent growth, making it a candidate for long-term investors.

Via Chartmill

2 Large-Cap Stocks with Competitive Advantages and 1 to Approach with Caution

June 09, 2025

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth...

Via StockStory

Topics Fraud

3 Cash-Heavy Stocks with Competitive Advantages

June 06, 2025

Companies with more cash than debt often have stronger financial flexibility, making them attractive in uncertain markets. Without interest payments being less of a worry, these businesses can invest...

Via StockStory

2 Healthcare Stocks to Keep an Eye On and 1 to Turn Down

June 02, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...

Via StockStory

Topics Stocks

1 Surging Stock with Exciting Potential and 2 to Avoid

May 23, 2025

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage...

Via StockStory

ResMed Draws Analyst Skepticism After Apnimed Announces Positive Results From Investigational Sleep Apnea Drug: Retail’s Unmoved ↗

May 20, 2025

RBC Capital noted that ResMed now has “a number of competitive threats on the horizon."

Via Stocktwits

Topics Government

What's going on in today's pre-market session: S&P500 movers ↗

May 20, 2025

Get insights into the top gainers and losers in the S&P500 index of Tuesday's pre-market session.

Via Chartmill

May 20, 2025

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...

Via StockStory

RESMED INC (NYSE:RMD) – A Quality Stock with Strong Fundamentals ↗

May 19, 2025

RESMED INC (NYSE:RMD) is a high-quality stock with strong revenue growth, exceptional profitability, and a solid balance sheet, making it a standout pick for long-term investors.

Via Chartmill

3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term ↗

May 18, 2025

Via The Motley Fool

Topics Retirement

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

ResMed Inc. Common Stock (NY:RMD)

All News about ResMed Inc. Common Stock

Starting at $3.75/week.

Subscribe Today